WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1990003796) PHARMACEUTICAL COMPOSITIONS COMPRISING CALCITONIN FOR INTRANASAL ADMINISTRATION AND A SPRAY UNIT FOR THE ADMINISTRATION OF THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1990/003796    International Application No.:    PCT/EP1989/001186
Publication Date: 19.04.1990 International Filing Date: 09.10.1989
Chapter 2 Demand Filed:    07.05.1990    
IPC:
A61K 9/00 (2006.01), A61K 38/23 (2006.01), B05B 11/00 (2006.01), B65D 83/14 (2006.01)
Applicants: SCHIAPPARELLI SALUTE S.P.A. [IT/IT]; Piazza Duca d'Aosta, 12, I-20124 Milano (IT) (For All Designated States Except US).
MARDENTE, Salvatore [IT/IT]; (IT) (For US Only).
CORNELI, Rodolfo [IT/IT]; (IT) (For US Only).
CARAZZONE, Marilena [IT/IT]; (IT) (For US Only)
Inventors: MARDENTE, Salvatore; (IT).
CORNELI, Rodolfo; (IT).
CARAZZONE, Marilena; (IT)
Agent: MINOJA, Fabrizio; Via Rossini, 8, I-20122 Milano (IT)
Priority Data:
22257 A/88 11.10.1988 IT
22548 A/88 08.11.1988 IT
Title (EN) PHARMACEUTICAL COMPOSITIONS COMPRISING CALCITONIN FOR INTRANASAL ADMINISTRATION AND A SPRAY UNIT FOR THE ADMINISTRATION OF THE SAME
(FR) COMPOSITIONS PHARMACEUTIQUES COMPRENANT DE LA CALCITONINE POUR ADMINISTRATION INTRANASALE ET UNITE DE VAPORISATION SERVANT A L'ADMINISTRATION D'UNE TELLE COMPOSITION
Abstract: front page image
(EN)Liquid pharmaceutical compositions for intranasal administration, consisting of a therapeutically effective amount of calcitonin dissolved in a sodium chloride solution in depurated water adjusted to pH 3.5-4.5, and a spray unit for the spray administration of the same, are disclosed.
(FR)La présente invention se rapporte à des compositions pharmaceutiques liquides pour administration intranasale, qui contiennent une quantité thérapeutiquement efficace de calcitonine dissoute dans une solution de chlorure de sodium qui est contenue dans de l'eau dépurée et dont le pH est réglé entre 3,5 et 4,5, ainsi qu'à une unité de vaporisation servant à l'administration d'une telle composition par vaporisation.
Designated States: AU, BB, BG, BR, DK, FI, HU, JP, KP, KR, LK, MC, MG, MW, NO, RO, SD, SU, US.
European Patent Office (AT, BE, CH, DE, FR, GB, IT, LU, NL, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CM, GA, ML, MR, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)